HomeFile

File

EuroPCR 2026 | Are bioresorbable stents making a comeback? Five-year results of FUTURE-II with Firesorb

The first bioresorbable coronary scaffolds generated great expectations because of their potential to restore vascular physiology after...

EuroPCR 2026 | Coronary bioadaptor: fewer events regardless of IVUS or FFR guidance

Despite the increasing use of intracoronary imaging and physiology, stent-related events continue to occur at an annual...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus...

EuroPCR 2026 | Restoring vascular physiology: 4-year results of the BIOADAPTOR-RCT

Despite advances in drug-eluting stents, device-related events continue to increase beyond the first year after angioplasty. In...

EuroPCR 2026 | Orbital versus rotational atherectomy: different impact on the microcirculation?

Not all calcium modification devices interact with the treated vessel in the same way. Although the clinical...

EuroPCR 2026 | Rotational atherectomy, orbital atherectomy, or lithotripsy: does device selection modify prognosis?

In the complex setting of severe coronary calcification, different plaque modification strategies have been incorporated into the...

EuroPCR 2026 | Does calcium morphology define the choice between IVL and cutting balloon?

The treatment of calcified coronary lesions remains one of the most technically challenging scenarios in contemporary angioplasty....

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the...